CD45RA-Foxp3high but not CD45RA+Foxp3 low suppressive T regulatory cells increased in the peripheral circulation of patients with head and neck squamous cell carcinoma and correlated with tumor progression

Journal of Experimental and Clinical Cancer Research

Volumn 33, Issue 1, 2014, Pages

  Sun, Wei ^a   Li, Wei Jin ^a   Wu, Chang You ^b   Zhong, Hua ^a   Wen, Wei Ping ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY   (China)

Author keywords

CD45RA; Foxp3; Head and neck squamous cell carcinoma; T regulatory cells

Indexed keywords

CD45RA ANTIGEN; INTERLEUKIN 2 RECEPTOR ALPHA; TRANSCRIPTION FACTOR FOXP3; CD45 ANTIGEN; CYTOKINE; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; CANCER STAGING; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL PROLIFERATION; COHORT ANALYSIS; CONTROLLED STUDY; CYTOKINE RELEASE; FEMALE; FLOW CYTOMETRY; FUNCTIONAL STATUS; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HISTOPATHOLOGY; HUMAN; HYPOPHARYNGEAL SQUAMOUS CELL CARCINOMA; HYPOPHARYNX CARCINOMA; LARYNGEAL SQUAMOUS CELL CARCINOMA; LARYNX CARCINOMA; MAJOR CLINICAL STUDY; MALE; MOUTH SQUAMOUS CELL CARCINOMA; NASOPHARYNGEAL SQUAMOUS CELL CARCINOMA; NASOPHARYNX CARCINOMA; OROPHARYNGEAL SQUAMOUS CELL CARCINOMA; OROPHARYNX CARCINOMA; PERIPHERAL CIRCULATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; TUMOR GROWTH; BLOOD; DISEASE COURSE; HEAD AND NECK TUMOR; IMMUNOLOGY; METABOLISM; MIDDLE AGED; PATHOLOGY; SECRETION (PROCESS); SQUAMOUS CELL CARCINOMA; TUMOR CELL CULTURE; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD45; CARCINOMA, SQUAMOUS CELL; CELL PROLIFERATION; CYTOKINES; DISEASE PROGRESSION; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; T-LYMPHOCYTES, REGULATORY; TUMOR CELLS, CULTURED;

EID: 84899986511     PISSN: None     EISSN: 17569966     Source Type: Journal    
DOI: 10.1186/1756-9966-33-35     Document Type: Article

References (34)

1. Global cancer statistics, 2002. Parkin DM, Bray F, Ferlay J, Pisani P, CA Cancer J Clin 2005 55 74 108 10.3322/canjclin.55.2.74 15761078
2. Recent changes in the epidemiology of head and neck cancer. Curado MP, Hashibe M, Curr Opin Oncol 2009 21 194 200 10.1097/CCO.0b013e32832a68ca 19363341
3. Head and neck cancer. Forastiere A, Koch W, Trotti A, Sidransky D, N Engl J Med 2001 345 1890 1900 10.1056/NEJMra001375 11756581
4. Regulatory T cells: what role do they play in antitumor immunity in patients with head and neck cancer? Alhamarneh O, Amarnath SM, Stafford ND, Greenman J, Head Neck 2008 30 251 261 10.1002/hed.20739 18172882
5. The impact of CD4 + CD25+ Treg on tumor specific CD8+ T cell cytotoxicity and cancer. Khazaie K, von Boehmer H, Semin Cancer Biol 2006 16 124 136 10.1016/j.semcancer.2005.11.006 16443370
6. Regulatory T cells, tumour immunity and immunotherapy. Zou W, Nat Rev Immunol 2006 6 295 307 10.1038/nri1806 16557261
7. FOXP3+ regulatory T cells affect the development and progression of hepatocarcinogenesis. Kobayashi N, Hiraoka N, Yamagami W, Ojima H, Kanai Y, Kosuge T, Nakajima A, Hirohashi S, Clin Cancer Res 2007 13 902 911 10.1158/1078-0432.CCR-06-2363 17289884
8. CD4(+) CD25high regulatory T cells increase with tumor stage in patients with gastric and esophageal cancers. Kono K, Kawaida H, Takahashi A, Sugai H, Mimura K, Miyagawa N, Omata H, Fujii H, Cancer Immunol Immunother 2006 55 1064 1071 10.1007/s00262-005-0092-8 16328385
9. CD4 + CD25+ regulatory T cells in the peripheral blood of patients with breast cancer and nonsmall cell lung cancer. Okita R, Saeki T, Takashima S, Yamaguchi Y, Toge T, Oncol Rep 2005 14 1269 1273 16211295
10. The frequency and suppressor function of CD4 + CD25highFoxp3+ T cells in the circulation of patients with squamous cell carcinoma of the head and neck. Strauss L, Bergmann C, Gooding W, Johnson JT, Whiteside TL, Clin Cancer Res 2007 13 6301 6311 10.1158/1078-0432.CCR-07-1403 17975141
11. Immunomodulatory effects of total intravenous and balanced inhalation anesthesia in patients with bladder cancer undergoing elective radical cystectomy: preliminary results. Sofra M, Fei PC, Fabrizi L, Marcelli ME, Claroni C, Gallucci M, Ensoli F, Forastiere E, J Exp Clin Cancer Res 2013 32 6 10.1186/1756-9966-32-6 23374147
12. FOXP3 gene polymorphism is associated with hepatitis B-related hepatocellular carcinoma in China. Chen Y, Zhang H, Liao W, Zhou J, He G, Xie X, Fei R, Qin L, Wei L, Chen H, J Exp Clin Cancer Res 2013 32 39 10.1186/1756-9966-32-39 23759077
13. Circulating microRNAs in cancer: origin, function and application. Ma R, Jiang T, Kang X, J Exp Clin Cancer Res 2012 31 38 10.1186/1756-9966-31-38 22546315
14. Functional delineation and differentiation dynamics of human CD4+ T cells expressing the Foxp3 transcription factor. Miyara M, Yoshioka Y, Kitoh A, Shima T, Wing K, Niwa A, Parizot C, Taflin C, Heike T, Valeyre D, Mathian A, Nakahata T, Yamaguchi T, Nomura T, Ono M, Amoura Z, Gorochov G, Sakaguchi S, Immunity 2009 30 899 911 10.1016/j.immuni.2009.03.019 19464196
15. Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo. Zhou X, Bailey-Bucktrout SL, Jeker LT, Penaranda C, Martínez-Llordella M, Ashby M, Nakayama M, Rosenthal W, Bluestone JA, Nat Immunol 2009 10 1000 1007 10.1038/ni.1774 19633673
16. Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production. Allan SE, Crome SQ, Crellin NK, Passerini L, Steiner TS, Bacchetta R, Roncarolo MG, Levings MK, Int Immunol 2007 19 345 354 10.1093/intimm/dxm014 17329235
17. Functional characterization of CD4+ T cells in aplastic anemia. Kordasti S, Marsh J, Al-Khan S, Jiang J, Smith A, Mohamedali A, Abellan PP, Veen C, Costantini B, Kulasekararaj AG, Benson-Quarm N, Seidl T, Mian SA, Farzaneh F, Mufti GJ, Blood 2012 119 2033 2043 10.1182/blood-2011-08-368308 22138514
18. Mechanisms of impaired regulation by CD4(+) CD25(+)FOXP3(+) regulatory T cells in human autoimmune diseases. Buckner JH, Nat Rev Immunol 2010 10 849 859 10.1038/nri2889 21107346
19. CD4+ CD25+ Treg cells inhibit human memory gammadelta T cells to produce IFN-gamma in response to M tuberculosis antigen ESAT-6. Li L, Wu CY, Blood 2008 111 5629 5636 10.1182/blood-2008-02-139899 18388182
20. CD4 + CD25 + Foxp3+ regulatory T cells induce cytokine deprivation-mediated apoptosis of effector CD4+ T cells. Pandiyan P, Xheng L, Ishihara S, Reed J, Lenardo MJ, Nat Immunol 2007 8 1353 1362 10.1038/ni1536 17982458
21. Mechanisms of foxp3+ T regulatory cell-mediated suppression. Shevach EM, Immunity 2009 30 636 645 10.1016/j.immuni.2009.04.010 19464986
22. Increase in circulating Foxp3 + CD4 + CD25 (high) regulatory T cells in nasopharyngeal carcinoma patients. Lau KM, Cheng SH, Lo KW, Lee SA, Woo JK, van Hasselt CA, Lee SP, Rickinson AB, Ng MH, Br J Cancer 2007 96 617 622 10.1038/sj.bjc.6603580 17262084
23. Regulatory T cells and their prognostic value for patients with squamous cell carcinoma of the head and neck. Boucek J, Mrkvan T, Chovanec M, Kuchar M, Betka J, Boucek V, Hladikova M, Betka J, Eckschlager T, Rihova B, J Cell Mol Med 2010 14 426 433 10.1111/j.1582-4934.2008.00650.x 19183242
24. Relationships between regulatory T cells and CD8 + effector populations in patients with squamous cell carcinoma of the head and neck. Chikamatsu K, Sakakura K, Whiteside TL, Furuya N, Head Neck 2007 29 120 127 10.1002/hed.20490 17103408
25. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Curiel TJ, Coukos G, Zou L, Alvarez X, Cheng P, Mottram P, Evdemon-Hogan M, Conejo-Garcia JR, Zhang L, Burow M, Zhu Y, Wei S, Kryczek I, Daniel B, Gordon A, Myers L, Lackner A, Disis ML, Knutson KL, Chen L, Zou W, Nat Med 2004 10 942 949 10.1038/nm1093 15322536
26. Distribution of immune cells in head and neck cancer: CD8+ T-cells and CD20+ B-cells in metastatic lymph nodes are associated with favourable outcome in patients with oro- and hypopharyngeal carcinoma. Pretscher D, Distel LV, Grabenbauer GG, Wittlinger M, Buettner M, Niedobitek G, BMC Cancer 2009 9 292 10.1186/1471-2407-9-292 19698134
27. Prognostic value of tumor-infiltrating CD4+ T-cell subpopulations in head and neck cancers. Badoual C, Hans S, Rodriguez J, Peyrard S, Klein C, Agueznay Nel H, Mosseri V, Laccourreye O, Bruneval P, Fridman WH, Brasnu DF, Tartour E, Clin Cancer Res 2006 12 465 472 10.1158/1078-0432.CCR-05-1886 16428488
28. Prognostic value of arginase-II expression and regulatory T-cell infiltration in head and neck squamous cell carcinoma. Bron L, Jandus C, Andrejevic-Blant S, Speiser DE, Monnier P, Romero P, Rivals JP, Int J Cancer 2013 132 85 E93 10.1002/ijc.27728 22815199
29. Simultaneous infiltration of polyfunctional effector and suppressor T cells into renal cell carcinomas. Attig S, Hennenlotter J, Pawelec G, Klein G, Koch SD, Pircher H, Feyerabend S, Wernet D, Stenzl A, Rammensee HG, Gouttefangeas C, Cancer Res 2009 69 8412 8419 10.1158/0008-5472.CAN-09-0852 19843860
30. Characteristics of CD4 + CD25+ regulatory T cells in the peripheral circulation of patients with head and neck cancer. Schaefer C, Kim GG, Albers A, Hoermann K, Myers EN, Whiteside TL, Br J Cancer 2005 92 913 920 10.1038/sj.bjc.6602407 15714205
31. Toll-like receptors in regulatory T cells of patients with head and neck cancer. Wild CA, Brandau S, Lindemann M, Lotfi R, Hoffmann TK, Lang S, Bergmann C, Arch Otolaryngol Head Neck Surg 2010 136 1253 1259 10.1001/archoto.2010.195 21173376
32. Patients with oral squamous cell carcinoma are characterized by increased frequency of suppressive regulatory T cells in the blood and tumor microenvironment. Gasparoto TH, de Souza Malaspina TS, Benevides L, de Melo EJ, Jr CMR, Damante JH, Ikoma MR, Garlet GP, Cavassani KA, da Silva JS, Campanelli AP, Cancer Immunol Immunother 2010 59 819 828 10.1007/s00262-009-0803-7 20012605
33. Increased frequency and suppressive activity of CD127 (low/-) regulatory T cells in the peripheral circulation of patients with head and neck squamous cell carcinoma are associated with advanced stage and nodal involvement. Drennan S, Stafford ND, Greenman J, Green VL, Immunology 2013 140 335 343 23826668
34. Intracellular CTLA4 and regulatory T cells in patients with laryngeal squamous cell carcinoma. Erfani N, Khademi B, Haghshenas MR, Mojtahedi Z, Khademi B, Ghaderi A, Immunol Invest 2013 42 81 90 10.3109/08820139.2012.708376 23252863